Ekso Bionics Holdings, Inc. (EKSO):Last Trade:Ekso Bionics Holdings, Inc. (EKSO) ended its previous trading session at $3.07 with the Gain of 6.6%. The company’s market cap is $222.88 Million, and the average volume is $1.83 Million. The 52-Week High range of the stock is $4.9, while the 52-week low range is $0.99. The Price to Sales (P/S) of the stock is 29.72, while P/B (Price to Book) stands at 51.17. When we look at the Volatility of the company, Week Volatility is at 40.78% whereas Month Volatility is at 19.57%.For the ongoing Fiscal Quarter, 1 analysts have an average earnings forecast of $-0.1 per share. According to the Analysts, the Low Earnings estimate for the current quarter is $-0.1, while the High earnings estimate is $-0.1.Comparatively, EPS for the same quarter last year was $-0.4.According to 1 analysts, the Average Revenue Estimate for the current Fiscal quarter is $3.19 Million and the Low Revenue estimate is $3.19 Million, while the High Revenue estimate is $3.19 Million.Ekso Bionics Holdings, Inc. (EKSO) analysts on average have given a price target of $3 on EKSO stock.According to the Recommendation Trends of the stock polled by Zacks Investment Research for this month, the company has a consensus recommendation of 1 out of the scale from 1 to 5 where 1 stands for Strong Buy and 5 means Strong Sell.Vertex Pharmaceuticals Incorporated (VRTX):Previous Trade:Vertex Pharmaceuticals Incorporated (VRTX) shares Jumped 1.36% and ended the day at $148.55. Its 52-week high and low range is between $167.86 and $71.46. The company’s outstanding shares are 253.75 Million. The volume of the company in the last trading session was 1.17 Million. The stock has a market cap of 37.69 Billion. The Stock shows P/E value of 190.45 and Forward P/E of 50.67.According to Finviz reported data, The SMA20 of the stock is at 0.67%, SMA50 is -1.2 percent, while SMA200 is 13.72%. The stock is currently has its Return on Assets (ROA) value of 13.3 Percent. The Return on Investment and Return on Equity (ROE) values are -0.3 percent and 26.8 percent, respectively.The company’s ATR (Average True Range) is 3.9. The Weekly Volatility is 1.92% and the Monthly Volatility is 2.86%.When we look at the Analyst Recommendations of the stock, the company has 1.48 rating given by Analysts where 1 stands for Strong Buy and 5 stands for Strong Sell.Vertex Pharmaceuticals Incorporated (VRTX) analysts on average have given a price target of $3 on VRTX stock.Vertex Pharmaceuticals Incorporated’s Average Earnings Estimate for the current quarter is $0.53, according to consensus of 22 analysts. The low EPS estimate is $0, while the high EPS estimate is $0.91.Average Revenue Estimate of the company for the current Fiscal Quarter is $595.85 Million, according to consensus of 18 analysts. The higher end of the revenue estimate is $657.67 Million and the lower end is $562.54 Million.Your email address will not be published. Required fields are marked *Comment Name * Email * Website  

